Response of Hispanic Puerto Rican Multiple Sclerosis Patients Switched from High Efficacy Therapies to cladribine Tablets in a Real-World Setting

被引：0
|
作者：
Chinea, Angel [1 ]
Vega-Corteguera, Ramon [2 ]
Martinez-Maldonado, Viviana [2 ]
Vicente, Ivonne [2 ]
Navedo-Santos, Jessenia [1 ]
机构：
[1] San Juan MS Ctr, Guaynabo, PR USA
[2] Caribbean Ctr Clin Res, Guaynabo, PR USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2024年 / 30卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1763/1031
引用
收藏
页码：1112 / 1112
页数：1
相关论文
共 50 条
  • [21] Cladribine tablets in people with relapsing multiple sclerosis: A real-world multicentric study from southeast European MS centers
    Adamec, Ivan
    Jakob, Gregor Brecl
    Rajda, Cecilia
    Drulovic, Jelena
    Radulovic, Ljiljana
    Kes, Vanja Basic
    Lazibat, Ines
    Rimac, Julija
    Cindric, Igor
    Grzincic, Tihana
    Abicic, Ana
    Barun, Barbara
    Gabelic, Tereza
    Gomezelj, Sarah
    Mesaros, Sarlota
    Pekmezovic, Tatjana
    Klivenyi, Peter
    Skoric, Magdalena Krbot
    Habek, Mario
    JOURNAL OF NEUROIMMUNOLOGY, 2023, 382
  • [22] Real-World Effectiveness of Cladribine Tablets in Individuals with Multiple Sclerosis: Data from a Multi-Center Italian Study
    Lucchini, Matteo
    Borriello, Giovanna
    Haggiag, Shalom
    Nicoletti, Carolina
    Fantozzi, Roberta
    Buscarinu, Maria Chiara
    Ferrazzano, Gina
    Cortese, Antonio
    Marinelli, Fabiana
    Monteleone, Fabrizia
    Centonze, Diego
    Conte, Antonella
    Ferraro, Elisabetta
    Gasperini, Claudio
    Marfia, Girolama Alessandra
    Pozzilli, Carlo
    Salvetti, Marco
    Barbuti, Elena
    Bianco, Assunta
    Carlomagno, Vincenzo
    Cruciani, Alessandro
    De Giglio, Laura
    Dionisi, Claudia
    Ianniello, Antonio
    Malimpensa, Leonardo
    Nasello, Martina
    Nociti, Viviana
    Prosperini, Luca
    Tortorella, Carla
    Mirabella, Massimiliano
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 376 - 377
  • [23] Safety of high efficacy therapies in older people with Multiple Sclerosis: A real-world evidence study
    Silva, Berenice
    Casales, Federico
    Donoso, Claudia Burbano
    Varela, Lucia
    Heriz, Alejandra
    Gonzalez, Cecilia
    Miguez, Jimena
    Alonso, Ricardo
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2024, 90
  • [24] Real-world effectiveness of cladribine for Australian patients with multiple sclerosis: An MSBase registry substudy
    Lizak, Nathaniel
    Hodgkinson, Suzanne
    Butler, Ernest
    Lechner-Scott, Jeannette
    Slee, Mark
    McCombe, Pamela Ann
    Shaw, Cameron
    Skibina, Olga
    Vucic, Steve
    Shuey, Neil
    Barnett, Michael H.
    Parratt, John
    Butzkueven, Helmut
    Jack, Dominic
    Fabris, Jessica
    Kalincik, Tomas
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (03) : 465 - 474
  • [25] Comparative effectiveness of cladribine tablets versus fingolimod in the treatment of highly active multiple sclerosis: A real-world study
    Brownlee, Wallace J.
    Haghikia, Aiden
    Hayward, Brooke
    Waser, Nathalie
    Kayaniyil, Sheena
    Khan, Zaeem
    Duncan, Julie
    Millar, Stefanie
    Harty, Gerard T.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 76
  • [26] Determining Effectiveness of "Off-Label Therapies" for Multiple Sclerosis in a Real-World Setting
    Pandit, Lekha
    Mustafa, Sharik
    Sudhir, Akshatha
    Malapur, Puneeth
    D'Cunha, Anitha
    ANNALS OF INDIAN ACADEMY OF NEUROLOGY, 2024, 27 (03) : 250 - +
  • [27] Efficacy, tolerability and safety of teriflunomide in multiple sclerosis in a real-world clinical setting
    Oreja-Guevara, C.
    Orviz-Garcia, A.
    Guerra-Schulz, E.
    Lopez de Velasco, V.
    Lopez-Perez, F.
    Palacios, M.
    Gonzalez-Suarez, I.
    EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 544 - 544
  • [28] Two years efficacy and safety results from real world experience for cladribine tablets in management of relapsing multiple sclerosis in Qatar
    Garcia-Canibano, B.
    Zahir, F. Zamrath
    Safan, A.
    Ibrahim, F.
    Deleu, D.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 391 - 391
  • [29] Age-Stratified Real World Outcomes in People with Relapsing Multiple Sclerosis over 50 Years of Age After Switching to Cladribine Tablets from High Efficacy Disease Modifying Therapies
    Okuda, Darin
    Livingston, Terrie
    Moog, Tatum
    Smith, Alexander
    Burgess, Katy
    Wright, Crystal
    Hardeman, Paula
    Sguigna, Peter
    Tardo, Lauren
    Horton, Lindsay
    Greenberg, Benjamin M.
    Blackburn, Kyle
    Munoz, Shanan
    Chandler, Angela
    Piette, Elizabeth
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 385 - 386
  • [30] Real-World Effectiveness of Cladribine for Patients with Multiple Sclerosis: A Sicilian Multicentric Experience (Rewind Study)
    Arena, Sebastiano
    Chisari, Clara Grazia
    Toscano, Simona
    Bucello, Sebastiano
    Grimaldi, Luigi Maria
    Ragonese, Paolo
    Realmuto, Sabrina
    Cottone, Salvatore
    Maimone, Davide
    Finocchiaro, Chiara
    Reitano, Paola
    Patti, Francesco
    CURRENT NEUROPHARMACOLOGY, 2024, 22 (07) : 1271 - 1283
12345